Home / Transcripts / CRA International, Inc. (CRAI) · August 6, 2026

CRA International, Inc. (CRAI) Earnings Call Transcript

August 6, 2026

NASDAQ US Industrials Professional Services earnings 44 min

Earnings Call Speaker Segments

Eric Nierenberg executive
#1

Thanks, Rob, and hello everybody. I want to remind you that anything discussed on this call — including our guidance regarding future revenue and non-GAAP EBITDA margin, plus any other remarks about CRA's future business, operating results, or financial condition, such as those using the words expect, outlook, or comparable language — constitutes forward-looking statements under Section 21E of the Exchange Act. The information in such forward-looking statements reflects management's present expectations and is uncertain by nature. Because of numerous significant factors, including how demand for our services is affected by shifts in general and industry-specific economic conditions, actual performance and results could differ materially from what those statements express or imply. Further details about these factors appear in today's release and in CRA's periodic reports, among them our most recently filed annual report on Form 10-K and quarterly reports on Form 10-Q filed with the SEC. CRA assumes no obligation to update these forward-looking statements after the date of this call to reflect new information or developments. In addition, on this call we will refer to some non-GAAP financial measures and certain measures presented on a constant currency basis. We encourage everyone to refer to today's release and related CFO remarks for reconciliations of these non-GAAP financial measures to their GAAP comparable measures, and descriptions of the calculation of EBITDA and measures presented on a constant currency basis. I'll now hand things over to Paul for his report. Paul?

Paul Maleh executive
#2

Appreciate that, Eric, and hello everybody. We're glad you could be with us this morning. Following eight straight years of record annual revenue along with our strongest Q1 ever to kick off fiscal 2026, our Q2 revenue came in at $210.8 million. That marks a 12.8% rise versus the prior year and stands as CRA's biggest quarterly revenue ever. Once again, broad-based contributions defined CRA's financial results, showing both the caliber and the breadth of the portfolio. Eight practices posted year-over-year growth, accounting for 95% of total company revenue in the Q2. Six practices: Energy, Finance, Forensic Services, Intellectual Property, Life Sciences, and Risk, Investigations & Analytics, recorded double-digit revenue growth. Meanwhile, the Antitrust & Competition Economics practice set a new quarterly revenue record. On top of that, our North American and international operations fueled the quarter's revenue growth, up 8.7% and 32.9% respectively; this top-line result drove the highest Q2 profits in company history, with non-GAAP net income, earnings per diluted share, and EBITDA rising 9%, 14.9%, and 15.3% respectively. Over the Q2, we brought on more than 60 new consultants as headcount rose 3.3% against the Q2 of 2025, while consultant utilization edged up to 77% from 76% in the Q2 of 2025. The gains in overall consultant headcount and utilization were underpinned by ongoing replenishment of our sales pipeline. Average weekly project lead flow and new project originations stayed robust, with both metrics notching double-digit growth compared to the Q2 of 2025. Q2 revenue from CRA's Legal & Regulatory services climbed 10.1%. That growth drew support from trends in the wider legal market, as total case filings and total court judgments rose 11% and 5% respectively, against the Q2 of 2025. Shifting to the M&A market, worldwide M&A activity reached $2.85 trillion during the H1 of 2026, up 50% over year-ago levels and the strongest opening stretch for deal-making since records of this kind started in 1980. The Q2 of 2026 came to $1.6 trillion, a 31% gain over the Q1 of this year, exceeding $1 trillion for a fourth straight quarter and making it the largest quarter of worldwide M&A activity ever recorded. Given that environment, CRA's Antitrust & Competition Economics practice delivered its sixth consecutive record quarter, benefiting from ongoing merger-related activity and sustained demand for antitrust services. In the quarter, CRA was retained by Fivetran, the data foundation for AI, to advise on its merger with dbt Labs, the creator of dbt, or data build tool, and the leader in standards for AI-ready structured data. The CRA team gave economic assistance to Fivetran regarding competition and regulatory compliance aspects of the transaction in the United States. The parties announced their merger's completion on June 1st, 2026, uniting two category-defining platforms to usher in a new era of trusted open data infrastructure for AI at scale. Our Finance practice stayed active in complex commercial disputes and investigations throughout the quarter. When it came to bankruptcy issues, we were busy with cases centered on liability management transactions. Take the Serta Simmons Bedding litigation: a court decision came down on July 7th that granted CRA's clients over $400 million in damages plus prejudgment interest. The court's opinion leaned specifically on testimony from Marti Murray, a Senior Consultant at CRA, describing her analysis as more convincing than what the opposing expert offered. People have talked about what the Serta decision means in a lot of places, with several pieces appearing in The Wall Street Journal, Bloomberg Law, Law360, and other outlets. During Q2, our Forensic Services practice posted year-over-year growth above 20% and set a fresh quarterly revenue record, all while handling many kinds of crisis management situations our clients ran into. One instance: more than 8,000 universities hit an outage with Canvas software during a crucial exam week, and our team got out there fast to respond, examine what information was exposed, and help bring the software back up. On another front, CRA's Intellectual Property practice gave advice on several high-stakes litigation and valuation matters spanning a wide array of industries and legal forms; for instance, a global smartphone maker facing patent infringement claims in the Eastern District of Texas brought CRA in. Wi-Fi and cellular handoff features on that smartphone were at the heart of the case. Our engagement team ran several analyses aimed at rebutting the plaintiff's damages claim at trial. The jury turned down the plaintiff's request for over $100 million, granting only $3 million — matching what CRA's expert had stated at trial. In a separate matter, a CRA expert gave testimony in a high-stakes international arbitration centered on a patent dispute between two top telecommunication companies. The arbitration panel granted the royalty rate that CRA's expert had put forward, which saved the client millions of dollars. Through Q2, the Risk, Investigations & Analytics practice took on a number of sizable investigative, advisory, and damage-related expert assignments as revenue climbed by more than 20% year-over-year. As an example, a CRA team looked into — and will act as forensic accounting experts in — a civil litigation involving a fraudulent misrepresentation claim in the private aviation sector. As part of that work, the team reviewed documents, conducted investigative research, and studied bank account records and financial documentation to trace where funds moved and to substantiate that alleged payments and liabilities owed actually existed. The team also dug into what the defendant had represented about assets sold to plaintiffs. Shifting to our Management Consulting services, the Energy and Life Sciences practices both turned in revenue growth beyond 20% year-over-year. CRA's Energy practice kept delivering solid results across a varied client base, including utilities, private equity investors, electric system operators, and large energy consumers. During Q2, the practice counseled the executive leadership team at one of the country's biggest utilities on building out its Utility of the Future strategy, tackling the rise of distributed energy resources, surging demand from data centers, and chances for new utility products and services. PJM, which runs the electric grid for the Mid-Atlantic and parts of the Midwest, likewise chose the practice for an engagement spanning multiple years to build improved forecasts of data center load, since demand growth at levels never seen before is generating fresh difficulties for planning and investment across the system. At the same time, CRA's Energy practice kept counseling developers and operators of data centers on where to site, how to procure power, and what development approaches to use throughout the United States, and also assisted other sizable energy consumers in steering through markets that are growing more intricate and changing quickly. Within our Life Sciences practice, we went on assisting clients in shaping their strategies throughout the life cycle, at the level of both the franchise and the product. With one big pharma multinational, we have partnered with its R&D group to uncover fresh possibilities within a wide disease category. CRA's work employs AI tools tailored to the industry to examine markets and the dynamics of innovation, portfolio positioning, and recent licensing and acquisition deals, so as to pinpoint possible areas of focus. With a second big pharma multinational, we keep backing its worldwide launch approach for a potential blockbuster oncology offering. CRA's efforts centered on branded value propositions along with message testing aimed at healthcare professionals and patients.

Paul Maleh executive
#3

All told, I want to thank each of my coworkers for their efforts throughout the second quarter as we helped our clients tackle their most critical issues. As fiscal 2026 gets underway, this marks the strongest first half for both revenue and non-GAAP EBITDA in CRA's history; during that first half, measured in constant currency against fiscal 2025, the company brought in total revenue of $408.8 million alongside non-GAAP EBITDA of $49.7 million, which works out to a 12.2% margin. Because our first-half performance was solid and our pipeline remains healthy, we're raising the guidance for yearly revenue while keeping our profit margin outlook unchanged. Looking at the whole of 2026, again in constant currency versus fiscal 2025, our expectation is revenue between $805 and $820 million, with a non-GAAP EBITDA margin between 12.0% and 13.0%. That updated revenue outlook sits above the earlier $785 to $805 million range. The constant currency adjustment, we anticipate, will lower CRA's reported yearly revenue by roughly $2.5 million and trim reported yearly EBITDA by under $250,000 for fiscal 2026. What that tells us is that for the second half of fiscal 2026, the constant currency adjustment will lift reported revenue by about $500,000 and reported EBITDA by $100,000. As we noted before, amortization of non-cash forgivable loans — shown as an expense in our EBITDA presentations — should rise by roughly $15 million in fiscal 2026, mirroring talent investments meant to fuel profitable growth. That same non-cash forgivable loan amortization climbed by over $9 million in this year's first half compared with the first half of fiscal 2025, which means an increase of a bit more than $5 million is anticipated for the second half of fiscal 2026 versus the second half of fiscal 2025. One last reminder: fiscal 2026 goes back to CRA's standard 52-week calendar, while fiscal 2025 had an additional week in the fourth quarter, making it a 53-week year. We stay encouraged by how strongly the year has begun, by favorable market trends, and by the ongoing refilling of our sales pipeline. Even so, we keep in mind that shifting geopolitical, worldwide macroeconomic, and business circumstances may impact our operations. With that, I'll hand things over to Chad, and after him Eric, for some further remarks. Chad?

Chad Holmes executive
#4

Thanks, Paul, and hello to all of you. I'd like to bring you up to speed on our capital position and how we deployed capital in the quarter. When the quarter closed, we held $21.4 million in cash along with $219 million drawn on our revolving credit facility, which left us with net debt of $197.6 million. Those borrowings went toward working capital requirements across the first two quarters, and that includes covering annual bonus payments, just as we've done in years past. Beyond the usual bonus cycle, Q2 of 2026 brought net cash outlays of $18.2 million directed at talent investments, plus $1.6 million for traditional capital expenditures. In Q2, we handed back $31.4 million of capital to shareholders, made up of $3.6 million in dividend payments and $27.8 million to repurchase roughly 193,000 shares at an average price of $144 per share. So far this year, we've put $49.3 million toward buying back 309,000 shares in total, at an average price of $160 per share. That speaks to the board's and management team's long-held confidence in how much cash this business can generate, and to their view that the company's fundamental value is greater than the stock price we see today. Right now, we've got $16.6 million left that we can tap through our share repurchase program. When we closed out the second quarter of fiscal 2026, our overall liquidity stood at $98.7 million. That figure is made up of $21 million in cash and cash equivalents, along with an additional $77.3 million of borrowing room on our line of credit at the close of the quarter. This morning, we put out word about boosting and extending CRA's current credit facility, since it was getting close to its last year ahead of maturity. This new arrangement is set to last for a period of five years, with a total borrowing capacity reaching as much as $400 million. That figure breaks down into two pieces: a term loan of $75 million, plus a revolving credit facility worth $325 million. Within that revolver there's also a seasonal flex feature, letting CRA cut the commitment by $75 million whenever working capital needs are at their lowest. This larger arrangement takes the place of the credit facility CRA currently has, which had an August 2027 maturity date. It also speaks to how much CRA has grown since the earlier facility was put in place back in 2022, as well as management's confidence about what lies ahead for the company. Having said that, I'll hand things over to Eric, who has a few closing remarks. Eric?

Eric Nierenberg executive
#5

Thanks, Chad. Just a reminder that you can find more detailed commentary about our financial results in the investor relations section of our website, under Prepared CFO Remarks. Before we take questions, I'd like to share a few extra metrics tied to how we performed in the second quarter of fiscal 2026. On consultant headcount, we finished the quarter with 968 people, made up of 161 officers, 581 other senior staff, and 226 junior staff. That's a 3.3% rise compared with the prior year, up from the 937 consultants we reported at the close of Q2 fiscal 2025. Non-GAAP SGA expenses, once you exclude the 1.3% tied to commissions paid to non-employee experts, came to 15.5% of revenue in the second quarter of fiscal 2026, versus 16.3% during the same period last year. On a non-GAAP basis, our effective tax rate for Q2 of fiscal 2026 was 32.6%, up against 29.0% on a non-GAAP basis in Q2 of fiscal 2025. That rise mostly reflects growth in non-deductible executive compensation, partly offset by a remeasurement of deferred tax assets stemming from changes in current year state apportionment. For the rest of the year, our expectation is an effective tax rate between 33% and 34%, which puts the full-year tax rate in the 32% to 33% range. Shifting to the balance sheet, DSO came in at 113 days at the end of Q2, versus 100 days at the close of Q1 of fiscal 2026. The Q2 DSO figure breaks down into 68 days billed and 45 days unbilled. That wraps up our prepared remarks, so we'll now open the call for questions. Rob, please go ahead.

Andrew Nicholas analyst
#6

Hi, thank you, and good morning.

Paul Maleh executive
#7

Good morning.

Andrew Nicholas analyst
#8

Thanks, Paul, and good morning. That Management Consulting performance this quarter really stood out — I believe growth came in around 25% to 26%. Could you break that down a bit further for us? Which parts of that business are likely expanding at very strong rates? And perhaps you could address sustainability — not necessarily of that specific growth rate, but of durable demand for that business line specifically.

Paul Maleh executive
#9

Certainly. Both our Life Sciences practice and our Energy practice posted year-over-year increases above 20%. Those two, I'd say, turned in comparable year-over-year gains during Q1. For roughly the past two or three quarters, that trend has held steady for each of them. On the persistence question, one more point: each of these practices is seeing a strong flow of fresh opportunities come in, and they're turning those into business at rates that are the best they've ever had. So for both practices, the outlook over the next several months and a bit beyond is pretty encouraging. Over in Life Sciences, the work spans pricing and market access as well as litigation-related matters — a really healthy spread across that practice. And in Energy, utilities in the U.S. are going through a period of transformation unlike anything in their history. As I noted, we're receiving a substantial volume of inquiries regarding that—from utilities, private investors, and tech companies—and there's no indication it's fading or slowing down at all. We're quite pleased with what we deposited for the first half. For those two practices, we continue to feel optimistic about the second half.

Andrew Nicholas analyst
#10

Great, that's useful. Regarding the Antitrust segment, I believe the DOJ just announced certain modifications, aimed at, as I understand it, speeding up a number of merger reviews and cutting back on some information requests. So I'm curious about your perspective on those modifications, what effect they might have on your operations, and if you've observed any effect so far from them.

Paul Maleh executive
#11

Let me take the final question first. So far, we have not observed any effect whatsoever, whether favorable or unfavorable, I'd say, at this point. From what I understand, the intent behind the modification is to make merger reviews more focused and less onerous. It is not meant to remove Antitrust examination. That being said, should the reviews turn more targeted, it might in fact raise the benefit of nailing the economics early in the process.

Andrew Nicholas analyst
#12

If I could just fit in a few modeling points here. I suppose this has two parts, with the first being about that additional week. What's the right way to consider the possible headwind from it? Obviously it falls at the close of the year, so I'm uncertain whether we should model typical utilization for it, or whether it's a somewhat softer week that was tacked on during the prior quarter. Regarding the bigger revolver, could you address interest expense as well as your wider intentions for drawing on that revolver between now and year-end? Thank you.

Paul Maleh executive
#13

Of course. When you take the middle point of our revised revenue guidance range, it essentially points to fairly steady quarterly revenue for CRA all the way through 2026. I brought up that additional week in Q4 of 2025, simply so anyone building their models around year-over-year growth rates would account for it. That additional week in 2025 was exceptionally busy for a holiday period, so measured on a growth rate basis, I'd estimate it contributed roughly a 100 to 150-basis point effect, rather than merely the straightforward annual value, or average annual value, that an extra week would carry. I believe your question also touched on the new credit facility.

Andrew Nicholas analyst
#14

What about interest expense?

Paul Maleh executive
#15

Absolutely — honestly, we couldn't be happier about wrapping this up, okay? Four years have passed, and now we're moving into year five of the agreement we put in place back in 2022. Over that stretch, the company has grown by over 40%. I'd say we're in the middle of a stretch of faster growth. Both the board and management felt it was important to keep as much flexibility as possible, so we can support the company's operations within the year. The term piece of it was simply something that helped us and our banking partners deliver that highest level of flexibility. Relative to what our working capital requirements look like overall, $75 million really isn't much.

Andrew Nicholas analyst
#16

Thanks, Paul.

Paul Maleh executive
#17

Thank you, Andrew.

Marc Riddick analyst
#18

Hey, good morning.

Paul Maleh executive
#19

Hey, Marc.

Marc Riddick analyst
#20

I'd like to begin with the obviously wide-ranging momentum you're witnessing across many segments. Could you perhaps expand a bit on how you're thinking about visibility? Of course, there's a degree of confidence when it comes to lifting the guidance. Maybe compared with what history has shown, Paul, would you speak a bit about the amount of visibility you currently enjoy, plus how comfortable you are with some of those catalysts and drivers?

Paul Maleh executive
#21

I'm rather optimistic when it comes to CRA, regarding where the portfolio stands, and concerning what they've been producing on that front. If I had to name what causes me any hesitation, it's that each quarter I'm attempting to project from a height we've never reached previously. Never reached in terms of the financial results we report, correct? Eight straight years of continuing to hear, "This quarter's a record, that quarter's a record." We're forecasting from peaks. The positive side is I'm also seeing record amounts of new project opportunities, along with new high levels of new projects turning into revenue-generating assignments. I feel good about how things are lining up, yet I can't claim we've had experience at these heights. That's the price of success, I suppose.

Marc Riddick analyst
#22

That brings me nicely to what comes next, I suppose. We're looking at utilization running strong at 77%. From what I recall, historically you've offered some remarks about nearing roughly 80%. So I was curious whether you might take a moment to talk through that, along with what comfort levels look like for you regarding utilization figures and the ranges you'd feel at ease with, and perhaps how all of that could factor into hiring patterns — whether at the senior level, or in ramping up college students, or anything along those lines.

Paul Maleh executive
#23

Sure. That's quite a bit. Let me see whether I can get to it.

Marc Riddick analyst
#24

Apologies — I got a little carried away there for a moment.

Paul Maleh executive
#25

That's completely fine. Across 2024 and 2025, we really didn't experience any net growth in our number of employees. What happened over that stretch was that we shifted capacity away from certain parts of the organization that perhaps weren't producing the revenue levels we'd have anticipated, and redirected it toward areas experiencing growth and requiring additional resources. So the firm's ability to generate revenue went up, even though the employee count didn't necessarily follow. That portfolio optimization effort moved along substantially, to the point where by 2026 we're once again adding to our net head count. In Q2, we're up 3.3%. Assuming attrition continues at the same rate we've been seeing, my expectation is that we'll land in that mid-single-digit range for head count growth by the time the year ends. There'll be more updates on that topic. Turning to the medium term going forward, my consistent position has been that either head count has to shift, or revenue tracks in line with an expanding head count. My sense is that over the medium term, CRA aims to grow heads at a mid-single-digit pace on that measure. Regarding utilization, my belief is that even with head count expanding in the mid-single digits, we ought to sit in the mid to upper 70s when it comes to utilization. You're always going to encounter some fluctuation on the utilization side, especially, let's say, in quarters two and quarters three. What causes that? It's because we simultaneously have some of our more junior staff returning to school while also bringing aboard a large group of new university graduates. That transitional friction can sometimes create downward pressure on utilization during those specific quarters. But when averaged across the full year, our expectation of mid to upper 70s utilization still holds.

Marc Riddick analyst
#26

Okay, perhaps the final one from my side: could you spend a moment on how things are going abroad and what's fueling that, plus whether there are elements beneath the surface we don't usually hear about? International has performed quite well for some time now, and I'd like your thoughts on that momentum.

Paul Maleh executive
#27

Honestly, it hasn't merely been quite well — it's been astonishing. When I look at the figures, I ask the people around me, "Are these accurate?" A few points regarding that momentum. First, Life Sciences, along with our Antitrust & Competition Economics practice — both are performing spectacularly in our overseas business. Second, I want to emphasize that this is entirely organic. We haven't brought in any teams from outside. We haven't bought any companies. My colleagues are doing an incredible job nurturing talent from within their own pyramid, lifting those people to levels where they generate revenue, and gaining more market share. I can't say the precise figure, but I'm fairly confident that consulting operations in Europe aren't expanding somewhere in the 30%-40% range. We're quite happy. My colleagues deserve all the praise, in both Life Sciences and the competition practice across Europe.

Marc Riddick analyst
#28

Excellent. Thank you very much.

Paul Maleh executive
#29

Thank you, Marc.

Kevin Steinke analyst
#30

Hi there, this is great, thank you. Morning to all of you.

Paul Maleh executive
#31

Morning, Kevin.

Kevin Steinke analyst
#32

I'd like to begin by asking about a few of your other practice areas that we possibly haven't discussed as much during today's session. In addition to Antitrust & Competition Economics and Life Sciences, your two biggest practices, you also mentioned that Forensic Services saw double-digit growth, and that unit ranks among your top three largest practices, and I believe this extends a pattern you likewise saw in the Q1. Could you perhaps speak to what's driving that growth?

Paul Maleh executive
#33

Sure. A few quarters back, we discussed how AI factors in — people ask me all the time about the way AI is impacting our business. We chose a handful of terms that I believe most accurately describe what's happening at CRA, namely that AI acts as a productivity enhancer, a demand amplifier. Saying it's a demand amplifier doesn't imply that every bit of this is revenue we generated simply by deploying AI tools. At times, it's the complexity that AI brings into our markets. Take forensics, for instance: AI helps CRA operate more efficiently, helps corporate America operate more efficiently; it also helps the hackers get far better at wreaking havoc on companies around the world. It's difficult to claim AI hasn't produced this perverse effect on demand for the cyber incident response work within the forensic practice. They're witnessing a surge in that area, they're witnessing plenty of these hackers who are quite sophisticated in how they wield these tools, and it doesn't appear to be letting up at the moment.

Kevin Steinke analyst
#34

All right. You brought up too that Intellectual Property and Finance are seeing double-digit growth for the quarter. Is there anything you'd point to as far as what's driving demand in those practices at the moment?

Paul Maleh executive
#35

Nothing specific comes to mind. When it comes to Intellectual Property, we've discussed how the entire idea of property rights — and safeguarding those rights — will remain a top priority for companies worldwide, and that's exactly what we're observing. I can't identify any individual micro-level catalyst in that area or in Finance; they're simply performing well when it comes to engaging the market and capturing their share of cases, if not more. My understanding is that this marks Finance's second consecutive quarter of double-digit revenue growth. The steadiness and perseverance my colleagues are showing truly deserve praise.

Kevin Steinke analyst
#36

All right, that's helpful. Regarding the addition of senior-level people, could you perhaps give us an update on how successful you've been so far in 2026 at bringing aboard experienced talent who arrive with established client rosters, and how that could be shaping your expectations for the year? Also, what does the pipeline currently look like?

Paul Maleh executive
#37

Yes. On the subject of newly added senior personnel, the place to begin is the close to 30 vice presidents who joined CRA over the course of 2025. Our new colleagues have us delighted, and we're quite encouraged that as of now, after two quarters of 2026, they've surpassed what we anticipated when it comes to how quickly they're ramping up and what they're contributing in revenue. That has us genuinely pleased. Nothing suggests that this ramp shouldn't keep going in the coming quarters; that contribution has us thrilled; we managed to bring in a number of senior-level resources across Q1 and Q2. As for the guidance, typically hires made mid-year are anticipated to add only a minimal amount in that same year, since we recognize those people need some time to ramp up, after which their full contribution can be realized. When I'm within that year, I typically don't factor in any contribution from inorganic additions.

Kevin Steinke analyst
#38

Right, that's clear. Okay. So, you brought up those 30 new vice presidents who joined during 2025 — if we figure a decent chunk of them already had their own client rosters, how do you see things playing out once they're on the CRA platform? Can they grow their revenue production inside your organization compared with what they managed beforehand? In earlier periods, that appeared to be a major element of the organic growth narrative.

Paul Maleh executive
#39

Without question, it has been a major element of organic growth. When we discuss organic growth, same store sales expansion inside the business isn't the only piece. It also means ensuring we offer a more fruitful platform for our new senior colleagues to integrate into CRA. We take considerable pride in our track record: once these senior colleagues are inside the CRA platform, they produce at levels above what they saw at prior professional institutions. That's the aim, correct? You want a pleasant, balanced contribution between the company and the individual. I believe my practice colleagues have performed really well on that front, no matter whether it's in Legal & Regulatory and Management Consulting. Usually, what sometimes delays ramp is that many of these senior colleagues carry restricted covenants, whether straight out non-competes or non-solicitation of clients. They must burn through a lot of those covenants before reaching historical ramp levels. At times it's less about integration, and more about the restrictions that generally last roughly 12 months post joining CRA.

Kevin Steinke analyst
#40

Okay, that's clear. Thanks for fielding the questions, and congratulations on the strong results.

Paul Maleh executive
#41

Thanks, Kevin. I really appreciate that.

Paul Maleh executive
#42

Thanks for being with us on this call. Your interest in CRA means a lot to us, as does the backing you've given the company throughout the years; during the months ahead, we'll be taking part in conferences and meetings with investors, and we're eager to bring you an update when our Q3 call takes place. That brings today's call to a close. Thanks to all of you.

Operator operator
#43

That brings us to the end of today's call. At this point you're free to hang up, and we appreciate your joining us.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete CRA International, Inc. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to CRA International, Inc. earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.